The House Health Plan Makes Your Genes a Preexisting Condition
By Adam Roger,
WIRED
| 05. 04. 2017
Of all the provisions of the Affordable Care Act—“Obamacare,” if you’re on a first-name basis—the one that seemed the most uncontroversially humane was the guarantee that insurance companies could not use so-called preexisting conditions to deny coverage. If you had a chronic illness or had recovered from something and lost your insurance, or if you quit or got fired, you could still get onto a plan.
But the odds say that sick people stay sick or get sicker, and insurance companies don’t make a profit by paying out. By voting to repeal the ACA and replace it with … well, with something, not totally clear what, the Republican-led House of Representatives seems to have nuked the preexisting condition guarantee. The new bill, which passed in a close 217-213 vote, allows insurance companies to charge sick people more. According to one nonpartisan analysis, it allocates enough money to cover those higher rates for just 5 percent of people with preexisting conditions.
Think it can’t get worse? Hold, as the saying goes, my beer. The ACA specifically protected against discrimination...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...